Showing results (631-640 of 9,668) with videos related to
Sort By:
Pageof 967
Leukemia|September 11, 2009
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institutionF P S Santos, S Faderl, G Garcia-Manero, et al.Leukemia|September 11, 2009
The use of novel agents in the treatment of relapsed and refractory multiple myelomaJ P Laubach, A Mahindra, C S Mitsiades, et al.Leukemia|July 10, 2009
Array-based DNA methylation profiling in follicular lymphomaC O'Riain, D M O'Shea, Y Yang, et al.Leukemia|March 16, 2011
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast functionS Vallet, S Pozzi, K Patel, et al.Leukemia|March 5, 2011
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cellsM Coscia, F Pantaleoni, C Riganti, et al.Leukemia|March 19, 2011
Recurrent DNMT3A mutations in patients with myelodysplastic syndromesM J Walter, L Ding, D Shen, et al.Leukemia|March 12, 2011
CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expressionY Saito, S Nakahata, N Yamakawa, et al.Leukemia|August 1, 1997
Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60J Zavadil, J Brezinová, P Svoboda, et al.Leukemia|August 1, 1997
Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XIIJ E Rubnitz, F G Behm, C H Pui, et al.Leukemia|August 1, 1997
Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemiaW Fielder, U Graeven, S Ergün, et al.Pageof 967